Feasibility and Tolerance of Apatinib plus PD-1 Inhibitors for Previously Treated Advanced Gastric Cancer: A Real-World Exploratory Study

Figure 5

Overall survival curve of the 39 patients with advanced gastric cancer who received apatinib plus PD-1 inhibitor administration.